The FEATURE study provides the first prospective validation of FDG-PET/CT and PERCIST response criteria in patients presenting with bone-only or bone-dominant metastatic breast cancer, opening the ...
SEPTEMBER 3, 2025, NEW YORK – Breast cancers frequently spread to the bone, establishing tumors that are largely impervious to treatment and are associated with poor patient prognoses. A deficiency in ...
Hosted on MSN
Why bone metastases resist treatment: New method identifies immune cells shielding tumors
Researchers at Baylor College of Medicine and collaborating institutions have developed a method that reveals the cellular makeup of tissues that support metastatic cancer growth, which is the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results